FDA Stops Imports From Chinese Drugmaker Over Valsartan Recall

In this undated photo, the FDA has expanded its recall of valsartan which is found in certain drugs for heart and high blood pressure treatment. NTD TV screenshot

The U.S. Food and Drug Administration halted imports of drug ingredients made by a Chinese drug manufacturer after a massive recall of one of its drugs over cancer-causing ingredients.

China’s Zhejiang Huahai Pharmaceuticals, a bulk manufacturer of the heart and blood pressure medicine valsartan, recalled the product in the United States in July after the presence of N-nitrosodimethylamine (NDMA) was found.